Not applicableStudy completedNCT05042089What this trial is testingPredictive Imaging Features in Renal Cell CarcinomaWho this might be right forRenal Malignant Tumor Ankara Yildirim Beyazıt University 92
Testing effectiveness (Phase 2)Ended earlyNCT00098618What this trial is testingSorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaPapillary Renal Cell CarcinomaRecurrent Renal Cell Cancer+2 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00003390What this trial is testing6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04902040What this trial is testingPlinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesWho this might be right forAdvanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more M.D. Anderson Cancer Center 19
Early research (Phase 1)Looking for participantsNCT05873686What this trial is testingClinical Study of NXP900 in Subjects With Advanced CancersWho this might be right forAdvanced Solid TumorNSCLC (Non-small Cell Lung Cancer)Renal Cancer+3 more Nuvectis Pharma, Inc. 140
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Early research (Phase 1)Active Not RecruitingNCT04522323What this trial is testingEvaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell CarcinomaWho this might be right forAdvanced Renal Cell Carcinoma MedImmune LLC 67
Not applicableStudy completedNCT05579847What this trial is testingFeasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination ImmunotherapyWho this might be right forRenal Cell Carcinoma Stage IV H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Study completedNCT04846920What this trial is testingBelzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)Who this might be right forCarcinoma, Renal Cell Merck Sharp & Dohme LLC 29
Testing effectiveness (Phase 2)Study completedNCT00003585What this trial is testingBiological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney CancerWho this might be right forKidney Cancer University of New Mexico 35
Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT00423332What this trial is testingCediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma AstraZeneca 105
Not applicableActive Not RecruitingNCT02735252What this trial is testingPROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerWho this might be right forProstate CancerAdvanced Renal Cell CarcinomaAdvanced Urothelial Carcinoma+1 more University of California, San Francisco 156
Early research (Phase 1)Ended earlyNCT03138538What this trial is testingM8891 First in Human in Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Renal Cell Carcinoma EMD Serono Research & Development Institute, Inc. 27
Early research (Phase 1)UnknownNCT06182735What this trial is testingCD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Fudan University 9
Testing effectiveness (Phase 2)Looking for participantsNCT07087158What this trial is testingIBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma (RCC) Imbioray (Hangzhou) Biomedicine Co., Ltd. 30
Early research (Phase 1)Looking for participantsNCT06805825What this trial is testingThe c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitWho this might be right forGastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more Novelty Nobility, Inc. 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT04071223What this trial is testingTesting the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL StudyWho this might be right forAdvanced Renal Cell CarcinomaChromophobe Renal Cell CarcinomaClear Cell Renal Cell Carcinoma+6 more National Cancer Institute (NCI) 134
Early research (Phase 1)Ended earlyNCT06034860What this trial is testingStudy of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesWho this might be right forNon Small Cell Lung CancerHepatocellular CarcinomaMelanoma+8 more Molecular Templates, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT03190174What this trial is testingNivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersWho this might be right forEwing SarcomaPEComaEpithelioid Sarcoma+11 more Sarcoma Oncology Research Center, LLC 34